Tag: Lupin

Lupin Launches Generic of Novartis’ Gleevec®

Lupin Limited (Lupin) announced the launch of Imatinib Mesylate Tablets, 100 mg (base) and 400mg (base). Lupin's alliance partner Natco had received an approval from the United States Food and Drug Ad...

FDA Approved Lupin’s Generic of Pfizer to Market

Pharma major Lupin announced that it has received approval for its Atorvastatin Calcium Tablets USP, 10 mg, 20 mg, 40 mg, and 80 mg, from the United States Food and Drug Administration (FDA) to market...

EC Approved Indian Orphan Drug

The European Commission (EC) has approved NaMuscla (mexiletine) for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders from Indian drugmaker Lupin. Non-dys...

Lupin Plans to Develop First-to-Market Products

Drug maker Lupin is in the process of developing a pipeline of products under its new drug discovery programme to treat various diseases like cancer and metabolic disorders, a top company official sai...